Qizhidao data shows that Jiangsu GenScript Biotechnology Co., Ltd. was established on August 31, 2016, with a registered capital of US$123 million and 870 insured persons. It is a company mainly engaged in pharmaceutical manufacturing. National high-tech enterprise. The company has been awarded the qualifications and honors of "National-level Specialized, New and Small Giant Enterprise" and "Innovative Small and Medium-sized Enterprise".
In terms of intellectual property rights, Jiangsu GenScript Biotechnology Co., Ltd. has 14 software copyrights and 55 patent information. In addition, Jiangsu GenScript Biotechnology Co., Ltd. also directly controls one company.